Transcription Factor DLX5 As a New Target for Promising Antitumor Agents
- Authors: Timakhov RA1,2,3, Fedichev PO1, Vinnik AA1, Testa JR3, Favorova OO2
-
Affiliations:
- Quantum Pharmaceuticals
- Pirogov Russian National Research Medical University
- Fox Chase Cancer Centre
- Issue: Vol 3, No 3 (2011)
- Pages: 47-51
- Section: Articles
- Submitted: 17.01.2020
- Published: 15.09.2011
- URL: https://actanaturae.ru/2075-8251/article/view/10676
- DOI: https://doi.org/10.32607/20758251-2011-3-3-47-51
- ID: 10676
Cite item